Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
04/25/2025
04/26/2024
04/28/2023
04/29/2022
04/30/2021
Revenue
35,483
33,537
32,364
31,227
31,686
30,117
Revenue Growth (YoY)
7%
4%
4%
-1%
5%
4%
Cost of Revenue
12,363
11,606
11,091
10,622
9,971
10,355
Gross Profit
23,120
21,931
21,273
20,605
21,715
19,762
Selling, General & Admin
11,433
10,839
10,628
10,242
10,135
9,776
Research & Development
2,886
2,732
2,735
2,696
2,746
2,493
Operating Expenses
16,387
15,356
15,152
14,259
14,809
14,367
Other Non Operating Income (Expenses)
348
285
414
96
306
144
Pretax Income
5,564
5,628
4,837
5,364
5,517
3,895
Income Tax Expense
923
936
1,133
1,580
456
371
Net Income
4,613
4,662
3,676
3,758
5,039
3,606
Net Income Growth
8%
27%
-2%
-25%
40%
-25%
Shares Outstanding (Diluted)
1,289.5
1,289.9
1,330.2
1,333
1,351
1,354
Shares Change (YoY)
0%
-3%
0%
-1%
0%
0%
EPS (Diluted)
3.58
3.61
2.76
2.82
3.73
2.66
EPS Growth
8%
31%
-2%
-24%
40%
-25%
Free Cash Flow
5,409
5,185
5,200
4,580
5,979
4,885
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
65.15%
65.39%
65.73%
65.98%
68.53%
65.61%
Operating Margin
18.97%
19.6%
18.91%
20.32%
21.79%
17.91%
Profit Margin
13%
13.9%
11.35%
12.03%
15.9%
11.97%
Free Cash Flow Margin
15.24%
15.46%
16.06%
14.66%
18.86%
16.22%
EBITDA
8,660
8,382
7,814
8,044
8,639
7,178
EBITDA Margin
24.4%
24.99%
24.14%
25.75%
27.26%
23.83%
D&A For EBITDA
1,927
1,807
1,693
1,698
1,733
1,783
EBIT
6,733
6,575
6,121
6,346
6,906
5,395
EBIT Margin
18.97%
19.6%
18.91%
20.32%
21.79%
17.91%
Effective Tax Rate
16.58%
16.63%
23.42%
29.45%
8.26%
9.52%
Follow-Up Questions
What are Medtronic PLC's key financial statements?
According to the latest financial statement (Form-10K), Medtronic PLC has a total asset of $91,680, Net profit of $4,662
What are the key financial ratios for MDT?
Medtronic PLC's Current ratio is 2.1, has a Net margin is 13.9, sales per share of $25.99.
How is Medtronic PLC's revenue broken down by segment or geography?
Medtronic PLC largest revenue segment is Other, at a revenue of -89,000,000 in the most earnings release.For geography, U.S. is the primary market for Medtronic PLC, at a revenue of 17,171,000,000.
Is Medtronic PLC profitable?
yes, according to the latest financial statements, Medtronic PLC has a net profit of $4,662
Does Medtronic PLC have any liabilities?
yes, Medtronic PLC has liability of 43,656
How many outstanding shares for Medtronic PLC?
Medtronic PLC has a total outstanding shares of 1,281.93